Botanical species · safety record

Hesperis matronalis

The EFSA Compendium of Botanicals holds 5 constituent measurements for Hesperis matronalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hesperis matronalis L.

5Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardenolides	Seed	Solvent extraction	200 Milligram/kilogram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Glucohesperin	Seed	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Glucosinolates	Seed	—	—	—	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	—	LC-MS	No resolvable identifier
Hesperaline	Seed	—	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Christensen, Bo W., Kjaer, Anders. A mustard oil of Hesperis matronalis seed, 6-methylsulfinylhexyl isothiocyanate. Acta chemica scandinavica, 1963, p. 846-847.
Danielak, Roman., Borkowski, Boguslaw. New thioglucosides from seeds of dame's violet (Hesperis matronalis). Dissertationes pharmaceuticae et pharmacologicae, 1970, p. 143-148.
Bennett, Richard N., Mellon, Fred A., Kroon, Paul A. Screening crucifer seeds as sources of specific intact glucosinolates using ion-pair high-performance liquid chromatography negative ion electrospray mass spectrometry. Journal of Agricultural and Food Chemistry, 2004, p. 428-438.
Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. Hesperaline (HMDB29560).. Human metabolome database, 2012, vol. 3.0.
Tyfczynska, Julia., Borkowski, Boguslaw. Cardenolides in the seeds of Hesperis matronalis. Dissertationes pharmaceuticae, 1965, p. 519-526.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature